In these patients, tumor cells did not show activity in the IFNγ signaling pathway, resistance to the antiproliferative effects of IFNγ, and lack of surface expression of PD-L1 and MHC class I in response to IFNγ [35]. This evidence concerns the gene CD274 and neoplasm.